Literature DB >> 11492989

Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography.

F M Bengel1, B Permanetter, M Ungerer, S G Nekolla, M Schwaiger.   

Abstract

AIMS: To identify functional and metabolic correlates of impaired presynaptic sympathetic innervation in the cardiomyopathic human heart using non-invasive correlative imaging. METHODS AND
RESULTS: In 10 patients with idiopathic dilated cardiomyopathy, presynaptic catecholamine uptake sites were quantified by positron emission tomography with C-11 hydroxyephedrine. Oxidative metabolism was measured using C-11 acetate. Global and regional function was assessed by tomographic radionuclide angiography. Left ventricular ejection fraction in patients was 19%+/-10%. Myocardial hydroxyephedrine retention was abnormally low in 58%+/-38% of the left ventricles. Globally and regionally, hydroxyephedrine retention was significantly correlated with ventricular function (r=0.67, P=0.03 with left ventricular ejection fraction; r=0.31, P<0.01 with regional endocardial shortening). Multivariate analysis confirmed hydroxyephedrine retention as the closest independent determinant of left ventricular ejection fraction. Oxidative metabolism was determined by rate pressure product as a measure of workload (r=0.78, P<0.01) and peripheral vascular resistance as a measure of afterload (r=-0.61, P=0.06), but did not correlate with hydroxyephedrine retention (r=0.08 for global, r=0.04 for regional parameters).
CONCLUSION: Alterations of presynaptic sympathetic innervation in dilated cardiomyopathy are associated with impaired contractile function, suggesting a common pathogenetic pathway. Overall oxidative metabolism, however, was not directly correlated with these findings. Normal regulatory mechanisms for oxidative metabolism were operational. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11492989     DOI: 10.1053/euhj.2000.2556

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

1.  Cardiac receptor physiology and imaging: an update.

Authors:  Grace P Chen; Ramin Tabibiazar; Kelley R Branch; Jeanne M Link; James H Caldwell
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

2.  Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: 11C-hydroxyephedrine PET study.

Authors:  Tadao Aikawa; Masanao Naya; Masahiko Obara; Noriko Oyama-Manabe; Osamu Manabe; Keiichi Magota; Yoichi M Ito; Chietsugu Katoh; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-26       Impact factor: 9.236

Review 3.  Recent Advances and Clinical Applications of PET Cardiac Autonomic Nervous System Imaging.

Authors:  Nabil E Boutagy; Albert J Sinusas
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 4.  Evaluating presynaptic and postsynaptic innervation in heart failure.

Authors:  Grace P Chen; James H Caldwell
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 5.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

Review 6.  PET and SPECT in heart failure.

Authors:  Christoph Rischpler; Stephan Nekolla; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 7.  Assessment of cardiac sympathetic neuronal function using PET imaging.

Authors:  Frank M Bengel; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

Review 8.  Assessment of cardiac autonomic neuronal function using PET imaging.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

9.  Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?

Authors:  Jeroen J Bax; Mark Boogers; Maureen M Henneman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-22       Impact factor: 10.057

10.  Prediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction.

Authors:  Wataru Fujita; Ichiro Matsunari; Hirofumi Aoki; Stephan G Nekolla; Kouji Kajinami
Journal:  Ann Nucl Med       Date:  2016-05-18       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.